Oncology & Cancer

Stimulating the immune system to fight cancer

Cancer cells have evolved mechanisms to escape the body's immune defense. Agents that prevent immune escape are attractive targets for the development of new cancer therapies. Scientists led by Prof. Herbert Waldmann and ...

Oncology & Cancer

Predicting success in therapy with individualized cancer models

In the EU alone, 78,800 men died of prostate cancer last year. While tumors discovered at an early stage can often be completely removed by surgery and radiation therapy, the prospects of successful treatment are reduced ...

Oncology & Cancer

Errant DNA boosts immunotherapy effectiveness

DNA that ends up where it doesn't belong in cancer cells can unleash an immune response that makes tumors more susceptible to immunotherapy, the results of two UT Southwestern studies indicate. The findings, published online ...

Medical research

Treating autoimmune disorders with an inhaler rather than an IV

Nanoparticles continue to find wider use in medical treatments in everything from drug delivery to diagnosing disease. In nearly every case, these ultrafine particles are delivered to patients via injection or through an ...

Oncology & Cancer

Potential cancer therapy may boost immune response

A new approach to cancer therapy shows potential to transform the commonly used chemotherapy drug gemcitabine into a drug that kills cancer cells in a specialized way, activating immune cells to fight the cancer, according ...

Diseases, Conditions, Syndromes

Moderna vaccine confers at least 3 months immunity: study

The Moderna COVID-19 vaccine, which the company says was recently demonstrated to have 94 percent efficacy, causes the human immune system to produce potent antibodies that endure for at least three months, a study showed ...

page 7 from 40